RNA-seq analysis of DLBCL cell lines in response to chemotherapy
RNA-seq (gene expression) · human · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Diffuse large B-cell lymphomaThis series is part of our curated briefing on it.
- Samples
- 36 samples: 36 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor controlNature communications · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE224867_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA932818 and SRA study SRP421535. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 36 sample titles: 36 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7034609 DB_UT
- GSM7034610 DB_ADR
- GSM7034611 Karpas422_UT
- GSM7034612 Karpas422_ADR
- GSM7034613 RCK8_UT
- GSM7034614 RCK8_ADR
- GSM7034615 SUDHL10_UT
- GSM7034616 SUDHL10_ADR
- GSM7034617 U2932_UT
- GSM7034618 U2932_ADR
- GSM7034619 WSUDLCL2_UT
- GSM7034620 WSUDLCL2_ADR
- GSM7034621 OCILY1_UT
- GSM7034622 OCILY1_ADR
- GSM7034623 OCILY18_UT
- GSM7034624 OCILY18_ADR
- GSM7034625 RI1_UT
- GSM7034626 RI1_ADR
- GSM7034627 SUDHL2_UT
- GSM7034628 SUDHL2_ADR
- GSM7034629 SUDHL4_UT
- GSM7034630 SUDHL4_ADR
- GSM7034631 TOLEDO_UT
- GSM7034632 TOLEDO_ADR
- GSM7034633 CARNAVAL_UT
- GSM7034634 CARNAVAL_ADR
- GSM7034635 DOHH2_UT
- GSM7034636 DOHH2_ADR
- GSM7034637 NUDHL1_UT
- GSM7034638 NUDHL1_ADR
- GSM7034639 OCILY7_UT
- GSM7034640 OCILY7_ADR
- GSM7034641 SUDHL5_UT
- GSM7034642 SUDHL5_ADR
- GSM7034643 SUDHL6_UT
- GSM7034644 SUDHL6_ADR
- GSE277665 DOT1L and EZH2 cooperatively repress PRC2 targets to maintain the GC B cell identity in DLBCL [RNA-seq] 48 samples same disease briefing · shares dlbcl, rna-seq
- GSE252306 Comparing gene expression in ABT-199 (venetoclax) sensitive and resistant diffuse large B cell lymphoma cell (DLBCL) lines 12 samples same disease briefing · shares dlbcl, lines
- GSE283388 Gene Expression Profiling in Diffuse Large B-Cell Lymphoma (DLBCL) Cell Lines Treated with Selinexor 12 samples same disease briefing · shares dlbcl, lines
- GSE244622 Single-cell transcriptome sequencing provides insight into multiple chemotherapy resistance in a patient with refractory DLBCL: a case report 1 samples same disease briefing · shares dlbcl, chemotherapy
- GSE271299 Transcriptome analysis of toosendanin (TSN)-treated DLBCL cells 8 samples same disease briefing · shares dlbcl
- GSE280799 Expression Data from DLBCL Cell Line U2932 (Parental, CDC-Treated, and CDC-Resistant) and 8 DLBCL Patient Samples (5 High CDC-Sensitive, 3 Low CDC-Sensitive) 20 samples same disease briefing · shares dlbcl
- GSE249466 Bendamustine combined with rituximab induces pyroptosis to shape an "immunologically hot" tumor microenvironment in DLBCL cells via the STING pathway 12 samples same disease briefing · shares dlbcl
- GSE231624 (1) Effect of KLHL6 loss on the transcriptome in DLBCL upon NOTCH ligand stimulation. (2) Effect of KLHL6 and NOTCH2 loss on the transcriptome in DLBCL. (3) Effect of DLBCL-associated NOTCH2 mutants on the transcriptome in DLBCL. 48 samples same disease briefing · shares dlbcl
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.